IOB - Delayed Quote • USD Abbott Laboratories (0Q15.IL) Follow Compare 114.01 +0.87 +(0.77%) At close: January 17 at 7:05:47 PM GMT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0Q15.IL 1D 5D 1.14% 1M 6.14% 3M 6.14% 6M 6.14% YTD 1.16% 1Y 0.34% 5Y 34.49% All 196.25% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 0Q15.IL View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Declining Stock and Decent Financials: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? Stocks to watch next week: Netflix, United Airlines, Burberry, EasyJet and JD Wetherspoon Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand Jim Cramer on Abbott Laboratories (ABT): ‘Not Understood Very Well Because They’re Doing Tremendous Stuff When It Comes To Diabetes. People Don’t Seem To Care’ Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up Abbott (ABT) Outpaces Stock Market Gains: What You Should Know AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?